Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 IBS to Expand Pilot Production of Pre-filled Syringes to One Million Units - Medical Product Outsourcing
Product Releases

IBS to Expand Pilot Production of Pre-filled Syringes to One Million Units

Integrated BioSciences, Inc. (IBS) announces that its parent company, Unilife Medical Solutions, has signed an exclusive license agreement with sanofi-aventis, one of the world’s leading pharmaceutical companies, for the Unilife Ready-to-Fill Syringe (RTFS).  In this agreement, sanofi-aventis retains exclusive rights to the RTFS for a period of five years in exchange for a licensing fee of $16.4 million. IBS began pilot production of the pre-filled syringes earlier this year at its Lewisberry facility and expects to expand pilot production to 1 million units with annual volumes potentially expected to exceed 400 million units at full production.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters